Premier Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-41,814
Closed -$11.8M 138
2021
Q3
$11.8M Buy
41,814
+2,502
+6% +$820K 1.64% 27
2021
Q2
$13.6M Sell
39,312
-9,390
-19% -$2.84M 2.01% 19
2021
Q1
$13.6M Buy
48,702
+21,067
+76% +$5.68M 2.43% 15
2020
Q4
$6.77M Buy
+27,635
New +$7.13M 1.39% 32

Other funds holding BIIB

Premier Asset Management's BIIB Position: Q4 2021 in Review

Premier Asset Management sold out of Biogen (BIIB) in Q4 2021, closing a stake of 41,814 shares — an estimated $11.8M sold.

Premier Asset Management first reported a position in BIIB in Q4 2020 and held it in 4 quarters. The position peaked at $13.6M in Q1 2021. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Premier Asset Management reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • Premier Asset Management sold 41,814 Biogen shares in Q4 2021, an estimated $11.8M.
  • Premier Asset Management first reported a position in Biogen in Q4 2020 and held it in 4 quarters.
  • Premier Asset Management's Biogen position peaked at $13.6M in Q1 2021.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Premier Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.